References
1. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3(2):383-9.
2. Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556-64.
3. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140(10):795-801.
4. Page A, Clifford R, Potter K, Etherton‐Beer C. A concept analysis of deprescribing medications in older people. JPPR. 2018;48(2):132-48.
5. Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA internal medicine. 2015;175(5):827-34.
6. Reeve E, Wiese MD. Benefits of deprescribing on patients’ adherence to medications. Int J Clin Pharm. 2014;36(1):26-9.
7. Organization. FMoHWH. Drug Financing In Ethiopia. Addis Ababa, Ethiopia.: Federal Ministry of Health/World Health Organization.; 2007.
8. Admassie E, Melese T, Mequanent W, Hailu W, Srikanth BA. Extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar Teaching Referral Hospital, North West Ethiopia. J Adv Pharm Technol Res. 2013;4(4):183.
9. Tegegn HG, Erku DA, Sebsibe G, Gizaw B, Seifu D, Tigabe M, et al. Medication-related quality of life among Ethiopian elderly patients with polypharmacy: A cross-sectional study in an Ethiopia university hospital. PLoS One. 2019;14(3):e0214191.
10. Tegegn HG, Tefera YG, Erku DA, Haile KT, Abebe TB, Chekol F, et al. Older patients’ perception of deprescribing in resource-limited settings: a cross-sectional study in an Ethiopia university hospital. BMJ open. 2018;8(4):e020590-e.
11. Iyer S, Naganathan V, McLachlan AJ, Le Conteur DG. Medication withdrawal trials in people aged 65 years and older. Drugs Aging. 2008;25(12):1021-31.
12. Linsky A, Simon SR, Marcello TB, Bokhour B. Clinical provider perceptions of proactive medication discontinuation. Am J Manag Care. 2015;21(4):277-83.
13. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825-34.
14. Linsky A, Simon SR, Stolzmann K, Bokhour BG, Meterko M. Prescribers’ perceptions of medication discontinuation: survey instrument development and validation. Am J Manag Care. 2016;22(11):747-54.
15. Frazier SC. Health outcomes and polypharmacy in elderly individuals. J Gerontol Nurs. 2005;31(9):4-9.
16. Geller AI, Shehab N, Weidle NJ, Lovegrove MC, Wolpert BJ, Timbo BB, et al. Emergency department visits for adverse events related to dietary supplements. N Engl J Med. 2015;373(16):1531-40.
17. Anthierens S, Tansens A, Petrovic M, Christiaens T. Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract. 2010;11(1):65.
18. Bolmsjö BB, Palagyi A, Keay L, Potter J, Lindley RI. Factors influencing deprescribing for residents in advanced care facilities: insights from general practitioners in Australia and Sweden. BMC Fam Pract. 2016;17(1):152.
19. Fried TR, Tinetti ME, Iannone L. Primary care clinicians’ experiences with treatment decision making for older persons with multiple conditions. Arch Intern Med. 2011;171(1):75-80.
20. Herrmann M, Kip M, Lehmann B, Andrusch S, Straub H, Robra B. GP Medication prioritisation in older patients with multiple comorbidities recently discharged from hospital: a case-based bottom-up approach. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)). 2015;77(1):16-23.
21. Moen J, Norrgård S, Antonov K, Nilsson JLG, Ring L. GPs’ perceptions of multiple‐medicine use in older patients. J Eval Clin Pract. 2010;16(1):69-75.
22. Schuling J, Gebben H, Veehof LJG, Haaijer-Ruskamp FM. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract. 2012;13(1):56.
23. Sinnott C, Mc Hugh S, Boyce MB, Bradley CP. What to give the patient who has everything? A qualitative study of prescribing for multimorbidity in primary care. Br J Gen Pract. 2015;65(632):e184-e91.
24. Turner JP, Edwards S, Stanners M, Shakib S, Bell JS. What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals. BMJ open. 2016;6(3):e009781.
25. Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ open. 2014;4(12):e006544.
26. Tolson D, Rolland Y, Katz PR, Woo J, Morley JE, Vellas B. An international survey of nursing homes. J Am Med Dir Assoc. 2013;14(7):459-62.
27. Peterson GM, Naunton M, Deeks LS, Kosari S, Jackson SL, Boom K. Practice pharmacists and the opportunity to support general practitioners in deprescribing in the older person. JPPR. 2018;48:183-5.
28. Anderson K, Freeman C, Rowett D, Burrows J, Scott I, Rigby D. Polypharmacy, deprescribing and shared decision‐making in primary care: the role of the accredited pharmacist. JPPR. 2015;45(4):446-9.
29. Forsetlund L, Eike MC, Gjerberg E, Vist GE. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr. 2011;11(1):16.
30. Balsom C, Pittman N, King R, Kelly D. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial. Int J Clin Pharm. 2020.
31. Reeve E. Deprescribing tools: a review of the types of tools available to aid deprescribing in clinical practice. JPPR. 2020;50(1):98-107.
32. Tefera YG, Alemayehu M, Mekonnen GB. Prevalence and determinants of polypharmacy in cardiovascular patients attending outpatient clinic in Ethiopia University Hospital. PLoS One. 2020;15(6):e0234000.
33. Getachew H, Bhagavathula AS, Abebe TB, Belachew SA. Inappropriate prescribing of antithrombotic therapy in Ethiopian elderly population using updated 2015 STOPP/START criteria: a cross-sectional study. Clin Interv Aging. 2016;11:819.
34. Abegaz TM, Birru EM, Mekonnen GB. Potentially inappropriate prescribing in Ethiopian geriatric patients hospitalized with cardiovascular disorders using START/STOPP criteria. PLoS One. 2018;13(5).
35. Ali EE. Health care financing in Ethiopia: implications on access to essential medicines. Value in health regional issues. 2014;4:37-40.